In last trading session, Sionna Therapeutics Inc (NASDAQ:SION) saw 0.4 million shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $16.74 trading at -$1.59 or -8.67% at ring of the bell on the day assigns it a market valuation of $738.64M. That closing price of SION’s stock is at a discount of -50.48% from its 52-week high price of $25.19 and is indicating a premium of 56.63% from its 52-week low price of $7.26. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.18 million shares which gives us an average trading volume of 179.25K if we extend that period to 3-months.

Sionna Therapeutics Inc (NASDAQ:SION) trade information

Sionna Therapeutics Inc (NASDAQ:SION) showed a performance of 20.87% in past 30-days. Number of shares sold short was 2.83 million shares which calculate 19.79 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of 45 to the stock, which implies a rise of 62.8% to its current value. Analysts have been projecting 45 as a low price target for the stock while placing it at a high target of 45. It follows that stock’s current price would drop -168.82% in reaching the projected high whereas dropping to the targeted low would mean a loss of -168.82% for stock’s current value.

Sionna Therapeutics Inc (NASDAQ:SION)’s Major holders

Insiders are in possession of 7.20% of company’s total shares while institution are holding 93.43 percent of that, with stock having share float percentage of 100.68%. Investors also watch the number of corporate investors in a company very closely, which is 93.43% institutions for Sionna Therapeutics Inc that are currently holding shares of the company.

On the other hand, JPMorgan Trust II-JPMorgan Small Cap Growth Fund and Prudential Sector Funds, Inc.-PGIM Jennison Health Sciences Fund are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025 , the former fund manager was holding 1.26 shares of worth $21.03 million or 2.85% of the total outstanding shares. The later fund manager was in possession of 553.94 shares on May 31, 2025 , making its stake of worth around $9.27 million in the company or a holder of 1.26% of company’s stock.